Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations

Overview of attention for article published in Frontiers in oncology, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,750 followers.

Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations. https://t.co/Z7FsfMu8cB https://t.co/lVUVfFeGnR

15 Jul 2023

Reply Repost Favourite

New research: Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations: The development of immune checkpoint inhibitors has revolutionized the landscape of treatment of advanced melanoma in… #oncology https:

29 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.